AUPH EPS Estimates
Aurinia Pharmaceuticals Inc.
$16.78
+$0.16(+0.99%)
65
Overall
70
Value
63
Tech
63
Quality
Market Cap
$2.21B
Volume
389.00K
52W Range
$10.90 - $19.25
Target Price
$17.75
AUPH EPS estimates: the consensus estimate for Aurinia Pharmaceuticals Inc.'s current fiscal year is $0.90 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
AUPH EPS Estimates
- EPS estimate, current quarter
- $0.21
- EPS estimate, next quarter
- $0.16
- EPS estimate, current year
- $0.90
- EPS estimate, next year
- $1.08
- EPS growth, 3-year
- +68.87%
| Fiscal year | EPS |
|---|---|
| 2025 | $2.14 |
| 2024 | $0.04 |
| 2023 | $-0.54 |
| 2022 | $-0.76 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AUPH | $16.78 | +1.0% | 389.00K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Aurinia Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW